Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,23682,969,1.01 [0.94-1.09],0.821285938259392
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,23597,189,0.94 [0.79-1.11],0.4493595409287526
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,25554,186,0.90 [0.76-1.07],0.2257738482774831
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,18051,746,1.02 [0.94-1.12],0.5863194058292267
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,25486,118,0.84 [0.68-1.05],0.1232754060009282
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,24450,83,1.02 [0.79-1.31],0.8970224109940735
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",26906,117,0.86 [0.69-1.07],0.1639399997102817
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,26900,78,0.87 [0.67-1.14],0.3063008150368782
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,23843,63,1.03 [0.78-1.37],0.819058151379601
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,26252,116,0.97 [0.78-1.19],0.7445572315564116
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other septicaemia,26206,70,1.05 [0.80-1.37],0.747736316790556
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,26986,74,1.10 [0.85-1.43],0.4548819432199148
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other viral diseases,26949,99,1.00 [0.80-1.26],0.9950945277466688
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",26944,94,1.03 [0.81-1.30],0.8153608167517912
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Mycoses,26611,61,0.89 [0.66-1.20],0.43062463515878
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",25820,429,1.05 [0.94-1.17],0.3909166330110952
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,25521,130,1.02 [0.84-1.25],0.8360674106732805
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,25688,297,1.08 [0.95-1.24],0.22752978487921
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",22094,51,0.82 [0.59-1.15],0.2482893694786385
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",22107,64,nan [nan-nan],
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",22297,254,1.01 [0.88-1.17],0.8728605486266933
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",22305,262,nan [nan-nan],
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",22698,655,1.00 [0.91-1.09],0.994742316104302
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",22093,50,0.86 [0.62-1.20],0.3818665208382458
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,24204,1004,1.07 [1.00-1.15],0.0599341842997951
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",25932,286,1.06 [0.92-1.21],0.412832795662009
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,26648,106,1.05 [0.84-1.30],0.6718990196063899
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",27079,89,0.91 [0.71-1.16],0.4364173122002542
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm: Rectum,26860,56,1.34 [1.01-1.78],0.0395557506869029
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,27076,66,0.93 [0.70-1.24],0.6366204783660222
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm: Stomach,27122,52,0.91 [0.65-1.25],0.5480811835420245
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign lipomatous neoplasm,26899,270,1.06 [0.92-1.22],0.4039664444408174
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,27069,106,1.04 [0.83-1.30],0.721319381574925
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,27069,105,1.01 [0.81-1.26],0.9535343187574548
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",27004,68,1.04 [0.79-1.37],0.7698980478766952
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Haemangioma, any site",27005,67,1.07 [0.82-1.41],0.6092197541732514
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Melanocytic naevi,26912,257,1.03 [0.89-1.19],0.6990128457253504
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,27080,117,1.08 [0.88-1.33],0.4746313858881288
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Other benign neoplasms of skin,26976,226,1.03 [0.89-1.20],0.689897837174442
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm of breast,27059,138,0.91 [0.75-1.11],0.3603105523180915
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Leiomyoma of uterus,26565,980,1.02 [0.95-1.10],0.5889682712823885
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,25736,262,1.17 [1.02-1.35],0.0211875566577813
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,25483,443,1.12 [1.00-1.24],0.0442952564784708
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,25483,443,1.12 [1.00-1.24],0.0442952564784708
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),23955,408,1.10 [0.98-1.23],0.1135026440931099
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,26570,98,0.82 [0.64-1.04],0.0978758152055186
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,26778,106,0.92 [0.74-1.16],0.4918764994742564
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,22465,903,1.06 [0.98-1.15],0.1209804166342855
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,24831,883,1.02 [0.94-1.10],0.6752321494789588
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,25308,120,0.90 [0.72-1.11],0.3218542761039932
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Peripheral artery disease,26141,58,0.97 [0.72-1.32],0.8642285925141698
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,25295,107,0.94 [0.75-1.17],0.5745143018907499
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,25593,405,1.08 [0.96-1.22],0.1799162188497165
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,25584,396,1.09 [0.97-1.23],0.1471613491440927
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,25066,190,0.96 [0.79-1.15],0.6312745294288789
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",25071,189,0.95 [0.79-1.15],0.621628302393582
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,22274,712,1.06 [0.97-1.16],0.1930428476370216
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",21644,82,1.04 [0.81-1.34],0.7736724148650453
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,22222,660,1.06 [0.97-1.17],0.1982243499992797
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,21611,49,1.13 [0.82-1.55],0.4512801098123224
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",21633,71,1.11 [0.85-1.44],0.4501347016711564
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,Any mental disorder,22864,614,0.97 [0.89-1.07],0.5926785156833143
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",22367,117,0.92 [0.74-1.15],0.4519559758346416
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",26885,78,0.79 [0.60-1.04],0.0894142214270384
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",26924,46,0.79 [0.56-1.14],0.2067017372212384
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,25692,38,0.80 [0.54-1.18],0.2659698536805392
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",27072,38,0.80 [0.54-1.17],0.2513352286452581
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",22288,38,0.81 [0.55-1.19],0.2836815834986923
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,Alcohol dependence,25678,24,0.78 [0.47-1.30],0.3480857548400794
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,Smoking dependency,25575,35,1.05 [0.71-1.54],0.8128503402280726
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",22293,43,1.07 [0.76-1.51],0.6921264666124642
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",22627,377,1.01 [0.90-1.14],0.8547097803254127
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,Depression,25150,337,1.00 [0.89-1.14],0.9464963614757268
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,Depression or dysthymia,22411,295,1.07 [0.94-1.23],0.299442545369839
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",22396,146,0.98 [0.81-1.19],0.8280632676522712
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,Other anxiety disorders,25238,76,0.85 [0.65-1.12],0.2554201668348901
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Neurological diseases,23369,1606,1.04 [0.98-1.11],0.152986839859242
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,21355,176,1.03 [0.86-1.22],0.7697706068539228
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,26927,146,1.04 [0.86-1.26],0.6731881447795192
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,25800,419,0.99 [0.89-1.11],0.90943955883339
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Epilepsy,25518,137,0.99 [0.81-1.20],0.8841006486967566
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Migraine,25506,125,0.97 [0.79-1.19],0.7812547541064219
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",26686,117,0.96 [0.78-1.19],0.7354007903217485
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Transient ischemic attack,26429,58,1.12 [0.83-1.50],0.456741781014244
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other sleep disorders,25477,96,0.92 [0.73-1.17],0.5040415985090301
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Sleep apnoea,26708,67,0.88 [0.66-1.18],0.3972979803600517
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",25762,850,1.05 [0.97-1.14],0.2062112142209983
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",25031,119,1.00 [0.82-1.24],0.9628146966046338
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,25453,541,1.04 [0.94-1.15],0.4463745991722757
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,26865,75,1.00 [0.77-1.30],0.9890883651630148
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Hemiplegia,26846,56,0.96 [0.71-1.31],0.8195352950647661
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other neurological diseases,26639,119,0.92 [0.74-1.14],0.4303225455281584
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",26393,421,0.99 [0.89-1.11],0.8988097577503777
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,26218,246,1.02 [0.88-1.18],0.7944706052779609
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,26044,72,0.75 [0.57-1.01],0.0545652699871997
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,26102,130,1.03 [0.84-1.25],0.8037375766451639
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,26076,104,1.24 [1.00-1.53],0.0529499296272832
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,23054,177,1.15 [0.97-1.36],0.1112192682331602
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,23281,404,1.04 [0.92-1.16],0.5489610103421141
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,26083,179,1.10 [0.93-1.30],0.2723352879153351
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,26854,34,1.19 [0.82-1.74],0.3577010850397631
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1741,34,1.15 [0.78-1.69],0.4861651116193237
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",25147,34,1.20 [0.82-1.74],0.3436649863134694
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,26425,90,0.99 [0.78-1.27],0.9645421534479648
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,26387,52,0.92 [0.67-1.28],0.6313581011037038
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",26296,95,0.97 [0.77-1.23],0.8248080479340215
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,26553,103,0.96 [0.76-1.20],0.7171470827326627
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,27000,128,1.19 [0.98-1.45],0.0768115231561288
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,26326,106,1.03 [0.83-1.29],0.777206714559035
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,19965,2763,1.05 [0.99-1.10],0.0814643687489006
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,26544,73,0.82 [0.62-1.09],0.1774077569864081
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Hypertension, essential",20957,2038,1.08 [1.02-1.14],0.008561806887711
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Hypertension,20978,2059,1.07 [1.02-1.14],0.0125331482286255
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,18967,48,0.76 [0.53-1.08],0.1239677541144082
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",25465,721,1.00 [0.92-1.09],0.9930625681572742
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Angina pectoris,25243,499,0.99 [0.89-1.10],0.9082244419030594
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,26461,146,0.92 [0.76-1.12],0.4021615464495542
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,26539,224,0.97 [0.84-1.14],0.7435856291743526
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",27054,26,1.21 [0.80-1.83],0.3625822846747895
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",24838,94,1.00 [0.79-1.27],0.994256853345359
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,25212,478,1.01 [0.91-1.12],0.8885999647372216
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Pulmonary embolism,26345,97,1.28 [1.03-1.60],0.0279172607926688
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Venous thromboembolism,26448,215,1.13 [0.97-1.32],0.1229671179450278
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Secondary right heart disease,26342,94,0.76 [0.59-0.98],0.0323365661250248
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,26342,94,0.76 [0.59-0.98],0.0323365661250248
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",19011,92,0.78 [0.61-1.01],0.0616213359872764
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Cardiomyopathy,23562,39,1.03 [0.71-1.49],0.8895175203041812
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Conduction disorders,23604,81,1.08 [0.84-1.38],0.5696140996739854
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16270,99,1.06 [0.84-1.33],0.6348822320532679
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,16445,274,0.87 [0.75-1.01],0.0710456886719328
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other arrhythmias,23574,51,0.83 [0.59-1.16],0.2788991298379975
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,23580,57,0.72 [0.52-0.99],0.0462869556301673
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Heart failure, strict",26291,101,1.09 [0.87-1.36],0.4713712659690177
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",26342,127,0.92 [0.75-1.13],0.4282931976020082
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",26382,95,0.94 [0.74-1.20],0.6323177355934836
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",26454,83,0.96 [0.74-1.23],0.7320726549010015
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,26165,69,1.07 [0.82-1.40],0.6338648414767379
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,26206,110,0.91 [0.73-1.14],0.4219283827399066
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),25515,131,1.06 [0.86-1.29],0.5943596070836932
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,DVT of lower extremities,25490,106,1.11 [0.89-1.39],0.3403561405139347
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",26907,103,1.10 [0.88-1.38],0.3852385930637572
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Varicose veins,25988,604,0.95 [0.87-1.05],0.3321461189014243
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Hypotension,25995,92,0.95 [0.75-1.21],0.6840863477724817
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22039,2062,1.07 [1.02-1.13],0.011367876951931
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,26912,125,0.95 [0.77-1.17],0.6274216456048617
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Influenza and pneumonia,25505,195,0.95 [0.81-1.13],0.578299701061405
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",25487,177,0.98 [0.83-1.17],0.8486910403058665
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,26231,223,1.01 [0.87-1.18],0.863466605512196
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,26223,215,1.01 [0.87-1.18],0.8836187120445163
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,26358,557,1.04 [0.95-1.15],0.3921064773808427
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Chronic sinusitis,25914,113,1.15 [0.93-1.41],0.1954691925171376
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Nasal polyp,25881,80,1.05 [0.81-1.35],0.732013148017753
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",26151,350,1.03 [0.91-1.17],0.6118506303111878
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Deviated nasal septum,25936,135,1.11 [0.92-1.34],0.2925004823171968
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13071,65,0.95 [0.71-1.28],0.7495952699918191
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,24223,1139,1.10 [1.03-1.18],0.0054620941473755
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Early onset COPD,26070,152,1.20 [1.00-1.43],0.0499564633822034
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",26090,172,1.14 [0.96-1.35],0.1325659096774777
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",26090,172,1.14 [0.96-1.35],0.1325659096774777
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",25116,982,1.09 [1.01-1.17],0.0252152688923503
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Asthma,20144,982,1.10 [1.02-1.18],0.0133098225186715
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",19958,982,1.10 [1.02-1.18],0.0138358340896686
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",20130,968,1.09 [1.01-1.18],0.0197479492046531
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,26802,81,0.95 [0.74-1.23],0.7000548913649769
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Interstitial lung disease,25369,60,0.99 [0.74-1.33],0.9306992755547858
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",26875,60,0.99 [0.74-1.33],0.9504132832271128
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,25362,53,0.90 [0.65-1.24],0.5110861057968352
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Pleural effusion,25305,86,1.09 [0.86-1.39],0.4832160193968534
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other diseases of pleura,25408,189,1.06 [0.90-1.25],0.4753777623242436
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,25970,89,0.99 [0.78-1.27],0.9671577141868488
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18770,5925,1.02 [0.98-1.06],0.3200659050582011
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",26566,462,1.02 [0.91-1.13],0.7775933067187573
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,27079,105,1.11 [0.89-1.38],0.3505676156829641
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Impacted teeth,27084,95,1.17 [0.93-1.46],0.1830627912957605
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Dental caries,26206,102,0.87 [0.69-1.10],0.2528550604914442
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,26220,116,1.08 [0.88-1.33],0.4499366152953895
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,27071,116,1.13 [0.92-1.39],0.2386968366075441
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,26214,110,1.08 [0.87-1.34],0.4646773903296687
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,25921,79,0.99 [0.77-1.28],0.9514996643446844
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,26985,49,0.97 [0.70-1.35],0.8699281845933713
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,20503,222,0.92 [0.78-1.07],0.2776892133877747
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",22565,2284,1.00 [0.95-1.05],0.9581843595076216
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Oesophagitis,20559,278,1.15 [1.01-1.32],0.0387699202785473
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,21010,729,0.99 [0.91-1.08],0.8344345331951338
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,20361,80,1.14 [0.89-1.46],0.3023620172631528
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,20414,133,1.11 [0.92-1.35],0.2728852774066181
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Oesophageal obstruction,20322,41,1.02 [0.71-1.45],0.9252831150284084
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Gastric ulcer,20427,146,0.90 [0.74-1.10],0.2997035005565838
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Duodenal ulcer,20358,77,0.92 [0.71-1.20],0.5545024111653436
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",27032,55,0.85 [0.62-1.17],0.3194001721973509
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Chronic gastritis,20411,130,0.95 [0.78-1.16],0.6246114927104842
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),21106,825,0.98 [0.91-1.07],0.6980336696081042
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of appendix,26950,145,0.91 [0.75-1.11],0.3523241939716087
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Functional dyspepsia,20857,576,0.95 [0.87-1.05],0.343221422904933
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,20459,178,1.03 [0.86-1.22],0.7605758271094919
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,26990,140,0.90 [0.74-1.10],0.2948475102889033
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Acute appendicitis,26922,117,0.90 [0.72-1.11],0.3158598787748686
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Hernia,24262,1181,1.05 [0.98-1.13],0.1489072260221823
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Inguinal hernia,23147,66,0.99 [0.74-1.31],0.9226756802253192
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Umbilical hernia,23152,71,1.22 [0.94-1.60],0.1357157932300398
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Ventral hernia,23190,109,1.06 [0.85-1.32],0.5888955176819017
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,24021,940,1.05 [0.97-1.14],0.1956653411845381
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,26043,903,1.06 [0.98-1.14],0.160945435661487
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of intestines,21455,2157,1.03 [0.98-1.09],0.2339987858622457
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",26771,60,1.06 [0.79-1.41],0.7108475448701013
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",27045,88,1.01 [0.80-1.29],0.9054545736023673
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Crohn disease,25228,88,1.02 [0.80-1.30],0.8738345768481298
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Crohn's disease NAS,25204,64,0.96 [0.72-1.28],0.7979866293373048
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",26975,134,1.14 [0.94-1.38],0.1900764050273383
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Ulcerative colitis,25274,134,1.14 [0.94-1.38],0.1815302898462971
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",25260,120,1.10 [0.89-1.34],0.3813591064221763
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,25907,767,1.06 [0.98-1.15],0.156661421893177
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,25896,756,1.06 [0.98-1.15],0.1648691539791943
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,19401,103,1.04 [0.83-1.30],0.7314354617356025
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Intestinal stricture,26650,103,1.03 [0.83-1.29],0.7845183378015032
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",19363,65,1.02 [0.77-1.35],0.8872999777713977
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,19959,661,1.06 [0.96-1.16],0.2439147901177589
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,19537,239,0.95 [0.82-1.11],0.5284305526234065
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,19685,387,1.10 [0.98-1.24],0.1017232537235924
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Constipation,25425,344,1.08 [0.96-1.22],0.2177624930886186
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of peritoneum,26611,126,0.87 [0.71-1.07],0.1903517435315759
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,19421,123,0.93 [0.75-1.14],0.4692665664001944
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,19340,42,0.81 [0.56-1.17],0.2565817955126694
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,20184,886,1.05 [0.97-1.14],0.2123089148361929
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of intestine,19525,227,1.02 [0.87-1.19],0.8436573667139209
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,26593,108,0.84 [0.67-1.06],0.1465997164941457
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of liver,26335,104,0.77 [0.61-0.98],0.0313289875427498
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of liver,26286,55,0.83 [0.60-1.14],0.2427918829319095
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",25559,863,1.02 [0.94-1.11],0.5991360732439738
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Cholelithiasis,25421,725,1.02 [0.93-1.11],0.709692414384639
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Cholecystitis,24825,129,1.12 [0.92-1.37],0.2476839815334248
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,24763,67,0.90 [0.68-1.20],0.4927247349324044
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Acute pancreatitis,24755,59,1.02 [0.76-1.38],0.8783327062372661
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),26961,59,1.01 [0.75-1.37],0.9285625763064728
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of the digestive system,25756,298,1.18 [1.04-1.34],0.0128039560105748
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Intestinal malabsorption,25558,100,1.38 [1.11-1.70],0.0031331075470971
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Coeliac disease,25543,85,1.35 [1.07-1.70],0.0101402299775092
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",25496,38,1.14 [0.80-1.64],0.4574818897171542
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,25624,166,1.11 [0.93-1.32],0.2513293499619303
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,GI-bleeding,25614,156,1.09 [0.92-1.31],0.3229516588384747
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,23997,1595,0.97 [0.92-1.03],0.3427584973069326
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,26660,112,1.00 [0.81-1.24],0.9976597626685922
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,26667,454,0.98 [0.88-1.10],0.779791770728056
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,25559,691,1.03 [0.94-1.12],0.5584148986088615
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,26305,314,0.93 [0.81-1.06],0.2578542895069643
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",26060,69,0.88 [0.66-1.16],0.3634034599024989
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,26189,198,0.93 [0.79-1.10],0.4096974254682641
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,26834,88,1.08 [0.85-1.38],0.5086942196220527
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,26809,63,1.14 [0.86-1.50],0.3592219566057525
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,26795,49,1.06 [0.77-1.46],0.7106942824061417
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,26845,52,0.77 [0.55-1.09],0.137618132395742
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,26842,49,0.76 [0.54-1.08],0.127819192961476
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,26271,58,1.14 [0.85-1.52],0.3918989107042262
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,26567,354,0.98 [0.87-1.11],0.804563474652591
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,24971,103,0.94 [0.75-1.18],0.5764155267499425
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,25021,153,0.86 [0.71-1.05],0.1327219003297275
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,24979,111,0.89 [0.71-1.12],0.3175549509190715
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",25122,254,1.10 [0.95-1.26],0.2073429053793278
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,25096,228,1.07 [0.92-1.25],0.365306620430303
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,19102,4319,1.04 [1.00-1.09],0.0524978593065628
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,20807,2477,1.04 [0.99-1.10],0.0902116687601957
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,24343,1318,1.08 [1.02-1.16],0.0139385449472672
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,18541,211,1.11 [0.95-1.29],0.2019391374195347
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18840,510,1.04 [0.94-1.16],0.4468164350934539
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",26535,202,1.12 [0.96-1.31],0.1472343290638719
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,26551,184,1.13 [0.96-1.33],0.1561130400646906
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,19538,1208,1.07 [1.00-1.15],0.0642691072882987
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",22195,1208,1.06 [0.99-1.14],0.0838049686285739
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18341,11,0.66 [0.30-1.44],0.2955057382877176
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",26917,11,0.62 [0.29-1.35],0.227245194884428
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,18602,272,1.01 [0.87-1.16],0.9417356332226824
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,18415,85,1.06 [0.83-1.37],0.6354385983431976
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,18636,306,1.05 [0.92-1.21],0.4471485021388576
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",26919,154,1.13 [0.95-1.36],0.1762409210482187
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,18804,474,1.07 [0.96-1.20],0.2122393748684734
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18809,479,1.03 [0.92-1.15],0.6345170558349669
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,19712,1382,1.04 [0.98-1.11],0.2155984109362835
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18434,104,1.06 [0.84-1.32],0.6404463922585324
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),18745,415,1.02 [0.91-1.14],0.7936204428670635
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18410,80,1.05 [0.81-1.36],0.6919283005992188
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18433,103,1.15 [0.92-1.44],0.2200841036221824
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,18688,358,1.07 [0.95-1.21],0.2745931562329166
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,18633,303,1.08 [0.95-1.24],0.2363849721801957
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,20216,296,1.00 [0.87-1.14],0.9562297117092712
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,26321,216,0.90 [0.77-1.06],0.2146217035829235
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,26197,92,1.18 [0.94-1.49],0.1539129417100336
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,23200,82,1.10 [0.86-1.42],0.446815301078749
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,23420,302,0.89 [0.78-1.02],0.104638757789414
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,24132,1014,0.94 [0.88-1.02],0.1280820947834917
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,23331,213,0.92 [0.78-1.08],0.2965961644531019
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,23194,76,0.88 [0.67-1.16],0.3657008412013196
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",23928,810,0.95 [0.88-1.04],0.2616844185938017
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,23169,51,1.08 [0.79-1.48],0.6381513083213293
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,23355,237,0.95 [0.82-1.11],0.5042311384368385
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,23217,99,0.94 [0.74-1.19],0.6001671980395711
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,23209,91,0.97 [0.76-1.24],0.8256965575586166
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,23279,161,0.91 [0.76-1.10],0.3244358455494778
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,23193,75,1.01 [0.77-1.31],0.967722861954726
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,23470,352,0.98 [0.87-1.11],0.7873576797073133
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,23407,382,1.11 [0.99-1.25],0.0748173213176695
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,23096,71,1.02 [0.77-1.33],0.9075909959528716
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,23134,109,1.03 [0.83-1.28],0.7993409678697883
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,23168,143,1.26 [1.05-1.51],0.0129361666839683
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",23061,36,1.21 [0.84-1.74],0.3130038486678772
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,23080,55,1.09 [0.81-1.48],0.5709443025892204
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],23066,41,0.87 [0.60-1.26],0.4767877476631581
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,23299,274,1.03 [0.90-1.18],0.673419318412487
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,23084,59,0.86 [0.63-1.17],0.3308274944156603
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,23094,69,0.97 [0.74-1.29],0.8498111801716246
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,23162,137,1.18 [0.97-1.42],0.093265261818267
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,23103,78,0.88 [0.67-1.15],0.3386836939154686
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",23560,535,1.05 [0.95-1.17],0.296607221100843
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,23216,191,0.97 [0.82-1.15],0.7103913656407913
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,23311,286,1.02 [0.89-1.17],0.7294030645718937
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,24407,234,0.94 [0.81-1.10],0.4251904488643311
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,24652,479,0.89 [0.80-0.99],0.0355124979905382
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,24212,39,0.86 [0.59-1.26],0.44573459982671
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,24239,66,0.76 [0.57-1.03],0.0775397334624573
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,24289,116,0.85 [0.68-1.05],0.1355691648761461
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,22119,6018,0.97 [0.94-1.01],0.0936456503436349
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,24696,195,1.09 [0.93-1.28],0.2958101704391832
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,24544,43,1.35 [0.98-1.87],0.0696404493005379
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Acute renal failure,24865,35,1.32 [0.91-1.90],0.1441601477496702
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,24876,46,0.99 [0.71-1.39],0.9556038635485044
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,24870,40,1.22 [0.86-1.72],0.263077087898882
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Urolithiasis,26873,130,0.81 [0.66-1.00],0.0535989234688805
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,26751,64,1.01 [0.76-1.34],0.9702475356844114
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,26844,101,0.89 [0.70-1.12],0.3233247442893702
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,26776,33,0.65 [0.42-1.00],0.0492648982116886
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,24923,1233,0.98 [0.91-1.05],0.5194707078227117
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Cystitis,23821,131,1.00 [0.82-1.23],0.9686885769055632
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,23779,89,1.06 [0.83-1.34],0.6370433046944817
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,23855,165,1.00 [0.83-1.19],0.9592947817087312
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Urethral stricture,23776,86,0.89 [0.69-1.14],0.3558447812026699
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,24661,971,0.99 [0.91-1.06],0.7115411366187041
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Disorders of breast,26800,473,0.92 [0.83-1.03],0.1351427396035246
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,26474,147,0.94 [0.77-1.13],0.4985505204890764
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,26495,168,0.98 [0.82-1.17],0.8511628192421051
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,26438,111,0.82 [0.66-1.03],0.0863030102808437
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,26746,542,0.94 [0.85-1.04],0.2366059640859502
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,26334,130,0.80 [0.64-0.98],0.0327249766416089
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,26445,241,1.01 [0.87-1.17],0.9023435567157596
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,24702,4510,0.99 [0.95-1.02],0.440509313490258
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Endometriosis,20551,359,1.14 [1.01-1.28],0.0332981929193341
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,20288,96,1.36 [1.09-1.69],0.0062873204210757
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20356,164,1.12 [0.94-1.33],0.2214527297629334
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,20970,778,1.02 [0.93-1.10],0.7120168433465023
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,20600,408,0.96 [0.86-1.08],0.5242606059863759
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21128,936,0.96 [0.89-1.04],0.2809737976441123
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Uterine polyps,20502,310,0.90 [0.79-1.03],0.1312163768346531
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",20628,436,1.04 [0.93-1.16],0.5014718981980997
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,20287,95,1.00 [0.79-1.26],0.9684669541219068
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,20376,184,1.00 [0.84-1.18],0.9977708024193188
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",27076,260,1.05 [0.91-1.21],0.4769954392737828
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,27086,246,1.05 [0.91-1.21],0.4974855505178488
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,27111,137,1.12 [0.93-1.36],0.2299167510571741
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",27102,151,1.12 [0.93-1.34],0.2267505450243279
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20336,144,0.94 [0.77-1.14],0.5012466732638541
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20305,113,0.99 [0.80-1.23],0.920826234357258
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,20332,140,1.01 [0.83-1.22],0.9585800483128506
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Irregular menses,27007,463,1.10 [0.99-1.23],0.0621730213518945
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",21511,1319,1.04 [0.98-1.11],0.2042936353549453
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Menorrhagia,21050,858,1.03 [0.95-1.12],0.4644443316912012
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",27092,194,1.01 [0.86-1.19],0.8763926315700998
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,20652,460,0.96 [0.86-1.07],0.4692275600184892
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,20519,327,0.96 [0.85-1.09],0.5538723823012547
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21074,882,0.94 [0.86-1.01],0.1019603697800918
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Female infertility,20307,115,0.99 [0.80-1.23],0.9254267337149494
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",20300,108,0.97 [0.78-1.22],0.8050108853636092
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,27107,863,1.01 [0.93-1.10],0.8445122503417039
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,27112,1171,0.98 [0.91-1.06],0.6020619978451198
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,27108,463,1.01 [0.91-1.13],0.8170171123158652
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,26776,131,1.08 [0.89-1.32],0.4394671008953277
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,26834,189,0.95 [0.80-1.12],0.5397261094447137
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,26800,155,0.98 [0.81-1.18],0.8456769920616464
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",27127,165,0.97 [0.81-1.17],0.7750244391721475
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,27129,162,0.97 [0.81-1.17],0.7666699540924915
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,27124,406,0.89 [0.79-1.01],0.0705212991360217
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,26837,119,0.75 [0.60-0.94],0.01344480156742
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,26945,227,0.88 [0.75-1.03],0.1101792153334659
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,26389,145,1.10 [0.91-1.33],0.321653806554234
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,26440,196,0.92 [0.78-1.10],0.3609990277148368
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,26492,248,1.03 [0.88-1.19],0.7230226697544213
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,26388,144,1.10 [0.91-1.34],0.3124038617059731
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,26379,135,1.09 [0.90-1.33],0.3728344234328959
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,26393,149,0.87 [0.72-1.06],0.1804118573244665
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,26168,227,1.01 [0.86-1.18],0.9086398671534508
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],26364,423,0.93 [0.82-1.04],0.2042258143830388
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,26591,650,1.00 [0.91-1.11],0.9570924399564256
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",27129,165,1.03 [0.86-1.23],0.7392121103049616
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,25700,126,0.98 [0.80-1.20],0.8408425864291587
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",26040,99,0.95 [0.75-1.20],0.6702046908795263
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,27137,332,0.92 [0.81-1.05],0.2230179213813068
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,27056,251,0.84 [0.72-0.98],0.02818925902531
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",27124,247,1.05 [0.91-1.22],0.4871723279274309
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",27115,238,1.04 [0.90-1.21],0.5988117709268039
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",26836,43,0.84 [0.58-1.21],0.3426292682343284
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Falls/tendency to fall,24256,633,0.89 [0.81-0.98],0.020460945011872
